About Honz

Honz Pharmaceutical Co., Ltd., is a publicly listed company centered on medicines for children. It devotes to becoming the leading brand in the children’s healthcare industry in China.

Professional Production

Honz Pharma has five highly automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong, and is constructing a new manufacturing base meeting the EU GMP standards in Zhongshan, Guangdong.

Innovative Research & Development

Honz Pharma emphasizes the R&D and innovation of products, has dedicated advanced equipment and exceptional R&D staff, and has invested hundreds of millions of RMB in this field.

Product Center

Honz Pharma has formed an integrated structure of products, created a successful line of children’s medicines centered on “Honz” branded products, and launched unique Honz star products such as “Ruizhiqing”, “Kangzhisong”, “Kangzhitai”,and “Jinlishuang”.

Social Responsibility

2011, Honz Pharma jointly founded the Honz Healthy Growth Foundation with the China Children and Teenagers Foundation, with the mission statement of taking care of the healthy growth of children.

Contact Us

Honz will carry on the cooperate legacy of “Sincere, Caring, Innovative”, and shoulder the responsibility of caring for and supporting children’s health and well-being.

Your position is:Home>Medicines for Adults
Medicines for Adults

Pioglitazone Hydrochloride Orally Disintegrating Tablets

Jiapuxi

Product Brief

Exclusive hydrochloride orally disintegrating tablets Preferred medication for drug combination, elder people, patients with dysphagia

Product Details

1. Unique dosage form:Exclusive orally disintegrating tablets are suitable for elder people, patients with dysphagia and reduce side effects for gastrointestinal tract and liver.
2. Unique pharmacological properties: New generation of insulin sensitizing agents can delay the development of diabetes, reduce cardiovascular complications.
3. Protection of renal function:Slow down the development of diabetic nephropathy .Patients with renal impairment don’t have to adjust dosage when taking the tablets.  
4. Safety of medication is high: No serious liver toxicity of troglitazone and rosiglitazone on cardiovascular risk.

 

Return

Wechat Account:honzpharma

Copyright by Honz Pharmaceutical Co.,Ltd.    All rights reserved Powered by vancheer